Actavis Urges 2nd Circ. To Toss 'Dangerous' Antitrust Order
Actavis PLC has urged the Second Circuit to overturn a court order that it continue selling an immediate-release version of dementia drug Namenda in the New York attorney general's antitrust suit...To view the full article, register now.
Already a subscriber? Click here to view full article